The impact of severe lung disease on evidential breath analysis collection

Seccombe, Leigh M.; Rogers, Peter G.; Buddle, Lachlan; Karet, B.; Cossa, Gavina; Peters, Matthew J.; Veitch, Elizabeth M.

doi:10.1016/j.scijus.2016.04.004

Cited by 4 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As medical science has advanced, spirometry has been deployed to validate methods of obtaining breath samples for evidential purposes. [3][4][5][6][7][8] Much of this research has investigated impaired individuals and information on healthy individuals' ability to use the currently approved equipment is quite sparsefewer than 300 healthy individuals, i.e. those without lung disease, have been investigated.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Can all healthy adults use the current evidential breath alcohol analysers? An investigation using a large spirometry database

2023

View full text Add to dashboard Cite

People failing to give a specimen of breath at a police station are assumed to be deliberately obstructive and are charged with Failure to Provide under the Road Traffic Act 1988. However, spirometry records of 281,210 healthy individuals from UK BioBank showed that a significant minority cannot use existing evidential breath analysis machines. Women were three times more likely to be unable to use them than men (1.64% vs 0.54%) with the risk rising with age six-fold from those in their 40s (0.43%) to 2.7% in their 70s, with women more affected (0.65% to 3.8%). Short stature was a further risk factor: 2.6% of men and 3.8% of women below the 2nd percentile of height could not use the current machines, with almost one in ten elderly, short women unable to do so, while smokers aged 50+ were twice as likely as non-smokers of the same age to be unable to provide breath specimens.

show abstract

Section: Introductionmentioning

confidence: 99%

“…In 2016, Seccombe et al. 7 investigated 26 people with COPD and 24 with ILD (interstitial lung disease or pulmonary fibrosis), classified as “moderate” or “severe”. The study used the Lion Intoxilyzer 8000 in use in Australia, similar to but more recent than the 6000 model approved for use in the UK.…”

Section: Introductionmentioning

confidence: 99%